These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19927996)

  • 1. [Role of cholestasis in development of copper metabolism disorder in patients with chronic liver disease].
    Soboleva AV; Petrakov AV; Borunova ZhV; Noskova KK; Drozdov VN
    Eksp Klin Gastroenterol; 2009; (3):9-12. PubMed ID: 19927996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis in common chronic liver diseases.
    Jüngst C; Berg T; Cheng J; Green RM; Jia J; Mason AL; Lammert F
    Eur J Clin Invest; 2013 Oct; 43(10):1069-83. PubMed ID: 23927644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urinary copper in acute hepatic encephalopathy.
    Singh V; Bhattacharya SK; Sunder S; Kachhawaha JS
    J Assoc Physicians India; 1990 Jul; 38(7):467-9. PubMed ID: 2292550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intrahepatic cholestasis in chronic liver diseases].
    Golovanova EV; Petrakov AV; Noskova KK
    Eksp Klin Gastroenterol; 2011; (2):58-67. PubMed ID: 21560642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of copper and iron in biological samples of viral hepatitis (A-E) female patients.
    Afridi HI; Kazi TG; Kazi NG; Jamali MK; Sarfaraz RA; Arain MB; Kandhro GA; Shah AQ; Baig JA; Jalbani N; Ansari R
    Biol Trace Elem Res; 2009; 129(1-3):78-87. PubMed ID: 19104758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell status in alcoholic and non-alcoholic liver disease.
    Maruyama S; Hirayama C; Yamamoto S; Koda M; Udagawa A; Kadowaki Y; Inoue M; Sagayama A; Umeki K
    J Lab Clin Med; 2001 Nov; 138(5):332-7. PubMed ID: 11709657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study.
    Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Collier J
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):384-92. PubMed ID: 18403939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis, laboratory tests and histology in 245 patients with cholestasis.
    Stajić M; Milosavljević J; Begić-Janev A
    Acta Hepatogastroenterol (Stuttg); 1979 Oct; 26(5):375. PubMed ID: 525215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of alcoholic liver disease.
    Martini GA
    Tokai J Exp Clin Med; 1982 May; 7(3):305-13. PubMed ID: 7123569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic activity of cholestatic liver disease in alcoholics].
    Vavros B; Pribyl B; Horácek J
    Vnitr Lek; 1986 Feb; 32(2):138-43. PubMed ID: 3962195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and liver disease.
    Rust C; Gores GJ
    Am J Med; 2000 May; 108(7):567-74. PubMed ID: 10806286
    [No Abstract]   [Full Text] [Related]  

  • 15. Health-related quality of life in chronic liver disease: the impact of type and severity of disease.
    Younossi ZM; Boparai N; Price LL; Kiwi ML; McCormick M; Guyatt G
    Am J Gastroenterol; 2001 Jul; 96(7):2199-205. PubMed ID: 11467653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic and blood lead levels in patients with chronic liver disease.
    Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
    Horie Y; Yamagishi Y; Ishii H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of liver diseases in the GDR, 1979-1989].
    Truckenbrodt J; Schmidt H; Bohndorf HJ
    Gastroenterol J; 1991; 51(3-4):129-31. PubMed ID: 1811656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation.
    Fusai G; Dhaliwal P; Rolando N; Sabin CA; Patch D; Davidson BR; Burroughs AK; Rolles K
    Liver Transpl; 2006 Nov; 12(11):1626-33. PubMed ID: 16952166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma copper and zinc levels in chronic viral hepatitis.
    Meram I; Sirmatel F; Ahi S; Tarakcioglu M
    Saudi Med J; 2004 Aug; 25(8):1066-9. PubMed ID: 15322599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.